Drug Pipeline

NK Cells Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
6
Active Studies
2
Recruiting
4
Top Sponsors
Active Studies by Phase
Phase 1/2
2
Phase 1
3
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07411599 Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With… Colorectal Cancer Recruiting
NCT07551778 Allogeneic NK Cell Therapy Combined With Standard Maintenance Treatment in Advanced Solid… NSCLC (Advanced Non-small Cell Lung Cancer) Not Yet Recruiting
Phase 1
NCT05834244 A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid… Acute Myeloid Leukemia Recruiting
NCT02573896 Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells Neuroblastoma Active, Not Recruiting
NCT07579208 A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells… Phase 1 Not Yet Recruiting
Early Phase 1
NCT06318871 Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or… Renal Carcinoma Active, Not Recruiting
Sponsors Running NK Cells Trials
Disease Areas
Get alerts when NK Cells trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free